Volume 15, Issue 1 , Pages 1-7, January 2006
Increased von Willebrand Factor in Acute Stroke Patients With Atrial Fibrillation
Plasma level of von Willebrand factor (vWF) is a useful marker not only for endothelial dysfunction, but also for left atrial thrombogenesis. We measured plasma levels of vWF antigen and other coagulation and fibrinolysis markers in 183 consecutive patients with acute ischemic stroke and compared these data between patients with and without atrial fibrillation (AF). vWF correlated with severity, outcome, and infarct size and were significantly higher in the AF group than in the non-AF group. The positive correlations of vWF with plasmin-α2 plasmin inhibitor complex and soluble fibrin monomer complex, and higher levels of vWF in patients with than without spontaneous echo contrast, indicate thrombogenesis in the left atrium. Plasma levels of vWF may reflect thrombogenesis in patients with AF.
Key Words: von Willebrand factor , atrial fibrillation , acute ischemic stroke , hemostatic marker
To access this article, please choose from the options below
PII: S1052-3057(05)00126-6
doi:10.1016/j.jstrokecerebrovasdis.2005.09.005
© 2006 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Volume 15, Issue 1 , Pages 1-7, January 2006
